JNJ

JNJ AI Signal Analysis

Multi-agent conviction signals powered by SEC filings, insider trades, institutional holdings, and earnings data.

Unlock full JNJ analysis View pricing

Signals

Avg conviction

+23

Direction mix

1 bullish0 bearish

May 10, 2026

conviction

Bullish(low)

Johnson & Johnson's 3-year clinical exclusivity (March 4) and revocation of compliance-heavy Methods of Analysis Regulation (February 19) directly protect near-term revenue and reduce costs. Institutional inflows of $2.37B from CalPERS and Truist suggest strategic positioning, while gross profit growth (9.8% YoY) indicates fundamental resilience despite recent QoQ volatility. Regulatory tailwinds align with a 1-month horizon for catalyst-driven re-rating.

+29

+30

+23

Agent Breakdown

Fundamentals AgentNeutral

+10

Mixed signals: 9.8% YoY gross profit growth indicates underlying strength, but -75% QoQ gross profit suggests near-term volatility. Analysts show mild optimism (5.9% target above price) but limited upside. Earnings consistency remains uneven (2/4 beats).

Sources

ForensicForensic score: 100/100 (0 flags)
Filing ChangeFinancial Notes — moderate changes
Filing ChangeFinancial Notes — moderate changes
Filing ChangeFinancial Notes — moderate changes
Filing ChangeFinancial Notes — moderate changes
Filing ChangeFinancial Notes — significant changes
EarningsEPS beat: $2.70 vs $2.69 est (+0.3%)
Analyst TargetAnalyst consensus target: $234
Analyst RatingAnalyst consensus: 0 strong buy, 14 buy, 9 hold, 0 sell, 0 strong sell

Institutional AgentNeutral

+35

New positions from high-quality institutions (CalPERS, Bahl & Gaynor, Truist) totaling $2.37B offset three large (>25%) decreases, but lack of prior quarter data limits trend consistency assessment. Zero percent ownership change for new buyers suggests price appreciation, not position sizing.

Sources

13F HoldingCALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM (CIK 0000919079): 5994988 shares ($1465414K) +5994988 [NEW]
13F HoldingBAHL & GAYNOR INC (CIK 0000872259): 2721183 shares ($665165K) +2721183 [NEW]
13F HoldingTRUIST FINANCIAL CORP (TFC, TFC-PI, TFC-PO, TFC-PR) (CIK 0000092230): 994084 shares ($242993K) +994084 [NEW]
13F HoldingTRUIST FINANCIAL CORP (TFC, TFC-PI, TFC-PO, TFC-PR) (CIK 0000092230): 942166 shares ($230303K) +942166 [NEW]
13F HoldingLansforsakringar Fondforvaltning AB (publ) (CIK 0002059323): 791412 shares ($193451K) +791412 [NEW]

Options AgentNeutral

+11

Options flow analysis: IV at 28.9% percentile (52-week). P/C ratio: 0.56. Detected unusual volume activity (volume > 3x open interest). ATM mispricing detected (call: 21.1%, put: 72.6%).

Sources

IV DataIV metrics: 28.9% percentile, IV/HV ratio 1.35

Unlock agent-level analysis

See exactly what each AI agent found — forensic accounting flags, insider clusters, institutional shifts, and more.

Checking access…View pricing

Expression status: tradable

This signal passed the expression gate and has a trade plan attached.

Policy linkage: inferred company relevanceMechanism quality: specific

Trade Plan

Live Return

$221.43+0.0%

Entry: $221.32 · 3d elapsed / 30d horizon

Tracking

Entry Zone

In entry zone

$219.00

$223.00

Valid until Jun 10, 2026

Price Targets (30-day)

Bull

$235.00+6.1%

3-year exclusivity (March 4) + institutional inflows + 9.8% YoY gross profit growth

Base

$228.00+3.0%

Institutional positioning ($2.37B) + baseline earnings consistency (2/4 beats)

Bear

$215.00-2.9%

Margin compression from 340B rebate pilot + QoQ profit volatility

Stop Loss

$215.00

-2.9%

Position Size

2-3%

of portfolio

Risk/Reward

1.2x

base target

Unlock the trade plan

Get entry zones, price targets, stop loss levels, and position sizing for every signal.

Checking access…View pricing

Get the full picture on JNJ

Our AI analyst team runs 5 specialized agents on every stock. Unlock detailed breakdowns, trade plans, and real-time alerts.

Start for $9/mo View pricing

Not financial advice. For informational purposes only. Past performance does not guarantee future results.